HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Combined elective percutaneous coronary intervention and transapical transcatheter aortic valve implantation.

Abstract
There is no established strategy of how and when to treat coronary artery disease (CAD) in patients referred for transcatheter aortic valve implantation (TAVI). Simultaneous, single-stage treatment of both pathologies is a possible solution. We report our initial results of simultaneously performed transapical TAVI and elective percutaneous coronary interventions (PCI) in high-risk patients with severe aortic valve stenosis. Between April 2008 and July 2011, a total of 419 patients underwent transapical TAVI. Combined elective PCI and TAVI were performed in 46 (11%) patients. Only the most significant coronary lesion or lesions were treated. Technical success of the combined approach was 100%. The mean count of implanted stents per patient was 1.6 ± 1.0 (range, 1-5 stents). The 30-day mortality rates in the PCI and TAVI group was 4.3%. Survival at 12, 24 and 36 months of the PCI and TAVI group 87.1 ± 5.5, 69.7 ± 10.3 and 69.7 ± 10.3%, respectively. The results showed that the single-stage approach with combined elective PCI and TAVI is feasible and safe. It has become our primary choice for treatment of high-risk patients with severe aortic valve stenosis and CAD.
AuthorsMiralem Pasic, Stephan Dreysse, Axel Unbehaun, Semih Buz, Thorsten Drews, Christoph Klein, Giuseppe D'Ancona, Roland Hetzer
JournalInteractive cardiovascular and thoracic surgery (Interact Cardiovasc Thorac Surg) Vol. 14 Issue 4 Pg. 463-8 (Apr 2012) ISSN: 1569-9285 [Electronic] England
PMID22232234 (Publication Type: Journal Article)
Topics
  • Aged
  • Aged, 80 and over
  • Angioplasty, Balloon, Coronary (adverse effects, instrumentation, mortality)
  • Aortic Valve Stenosis (complications, diagnosis, mortality, therapy)
  • Cardiac Catheterization (adverse effects, mortality)
  • Coronary Angiography
  • Coronary Stenosis (complications, diagnosis, mortality, therapy)
  • Feasibility Studies
  • Female
  • Germany
  • Heart Valve Prosthesis Implantation (adverse effects, methods, mortality)
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Severity of Illness Index
  • Stents
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: